Citations

Showing 10 of 108094 citations.

Reflecting on the Bicentennial of Mary Shelley’s Frankenstein
Wijdicks, Eelco F. M.

Mayo Clinic

JAMA Neurology | December 26, 2017 | Volume: 75 | Issue: 2 | Pages: 149

10.1001/jamaneurol.2017.4000 | PMID 29279904 Get It

Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma
Nepal, Chirag , O’Rourke, Colm J. , Oliveira, Douglas V.N.P. , Taranta, A , Shema, Steven , Gautam, Prson , Caldéraro, Julien , Barbour, Andrew P. , Wennerberg, Krister , Wang, Xin Wei , Lautem, Anja , Roberts, Lewis R. , Andersen, Jesper B. , Roberts, Lewis R , Andersen, Jesper B , Wei Wang, Xin , Raggi, Chiara , Gautam, Prson , Wennerberg, Krister

Mayo Clinic

Hepatology | December 26, 2017 | Volume: 68 | Issue: 3 | Pages: 949-963

10.1002/hep.29764 | PMID 29278425 Get It

Intrahepatic cholangiocarcinoma remains a highly heterogeneous malignancy that has eluded effective patient stratification to date. The extent to which such heterogeneity can be influenced by individual driver mutations remains to be evaluated. Here, we analyzed genomic (whole‐exome sequencing, targeted exome sequencing) and epigenomic data from 496 patients and used the three most recurrently mutated genes to stratify patients ( IDH , KRAS , TP53 , “undetermined”). Using this molecular dissection approach, each subgroup was determined to possess unique mutational signature preferences, comutation profiles, and enriched pathways. High‐throughput drug repositioning in seven patient‐matched cell lines, chosen to reflect the genetic alterations specific for each patient group, confirmed in silico predictions of subgroup‐specific vulnerabilities linked to enriched pathways. Intriguingly, patients lacking all three mutations (“undetermined”) harbored the most extensive structural alterations, while isocitrate dehydrogenase mutant tumors displayed the most extensive DNA methylome dysregulation, consistent with previous findings. Conclusion : Stratification of intrahepatic cholangiocarcinoma patients based on occurrence of mutations in three classifier genes ( IDH , KRAS , TP53 ) revealed unique oncogenic programs (mutational, structural, epimutational) that influence pharmacologic response in drug repositioning protocols; this genome dissection approach highlights the potential of individual mutations to induce extensive molecular heterogeneity and could facilitate advancement of therapeutic response in this dismal disease. (H epatology 2018).
Registered nurse intent to promote physical activity for hospitalised liver transplant recipients
Pearson, Jocelyn A. , Mangold, Kara , Montez, Morgan, Smith, Diane, Tyler, Brenda, Smith, Diane M, Tyler, Brenda J, Kosiorek, Heidi

Mayo Clinic

Journal of Nursing Management | December 26, 2017 | Volume: 26 | Issue: 4 | Pages: 442-448

10.1111/jonm.12561 | PMID 29277974 Get It

Prevalence of and indications for antipsychotic use in Parkinson's disease
Bower, James H., Rocca, Walter A. , Savica, Rodolfo , Grossardt, Brandon R. , Rocca, Walter A

Mayo Clinic

Movement Disorders | December 26, 2017 | Volume: 33 | Issue: 2 | Pages: 325-328

10.1002/mds.27256 | PMID 29278275 Get It

ABSTRACTBackground: The prevalence of patients with PD taking antipsychotics is unknown.Objective: To measure the prevalence of patients with PD taking antipsychotics.Methods: We used the medical records‐linkage system of the Rochester Epidemiology Project to study the use of antipsychotic medication in all persons with Parkinson disease in Olmsted County, Minnesota on 1 January 2006.Results: There were 296 patients with PD in Olmsted County on 1 January 2006. The overall prevalence of antipsychotic use was 9.8% (29 of 296); 95.5% (28 of 29) of the patients had dementia when initiating antipsychotics. The most frequent indication (71.4%; 20 of 28) was psychosis or behavior threatening to the patient or others.Conclusions: The prevalence of antipsychotic use in patients with PD is lower than expected from previously reported cumulative incidences. Dementia is highly prevalent in those starting antipsychotics. Most of the patients on antipsychotics had a reasonable risk‐benefit ratio for taking them. © 2017 International Parkinson and Movement Disorder Society
Role of nitric oxide in intrarenal hemodynamics in experimental diabetes mellitus in rats
Pflueger, Axel , Larson, Timothy S., Hagl, Siegfried, Knox, Franklyn G.

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | December 25, 2017 | Volume: 277 | Issue: 3 | Pages: R725-R733

10.1152/ajpregu.1999.277.3.r725 | PMID 10484489 Get It

The role of nitric oxide (NO) in the regulation of the intrarenal microcirculation in streptozotocin (STZ)-induced diabetes mellitus in rats is not clear. We examined renal cortical and papillary hemodynamics in STZ rats and determined the effects of systemic inhibition and stimulation of NO synthesis. Renal blood flow in cortical (QCC), and inner medullary ascending (QAV) and descending (QDV) vasa recta capillaries was measured by fluorescence videomicroscopy in STZ Munich-Wistar rats and nondiabetic control rats. Ten days after STZ injection (80 mg/kg ip), basal QCCand QDVwere significantly greater in STZ rats ( n = 16) compared with control rats ( n = 15). Infusion of NG-monomethyl-l-arginine (l-NMMA, 15 mg/kg bolus, 500 μg ⋅ min−1⋅ kg−1iv) decreased QCC(−41%), QAV(−38%), and QDV(−37%) in control rats ( n = 6) and to a significantly greater magnitude than in STZ rats ( n = 7), QCC(−14%), QAV(−20%), and QDV(−25%). Coinfusion ofl-arginine (l-Arg, 1 mg ⋅ kg−1⋅ min−1iv) with l-NMMA increased QCCto a significantly greater extent ( P < 0.01) in control rats compared with STZ rats. In subsequent studies, infusion ofl-Arg alone increased QCC(+50%), QAV(+16%), and QDV(+11%) in control rats ( n = 5) but had no effect in STZ rats ( n = 5). These results show that the response of renal cortical and papillary capillary blood flow to both inhibition and stimulation of NO synthesis is attenuated in the early onset of STZ-diabetes mellitus rats compared with control rats.
HYPOPROTHROMBINEMIA DUE TO LOSS OF INTESTINAL LYMPH
Mann, Joseph D., Bollman, Jesse L., Mann, Frank D.

Mayo Clinic

American Journal of Physiology-Legacy Content | December 25, 2017 | Volume: 158 | Issue: 2 | Pages: 311-314

10.1152/ajplegacy.1949.158.2.311 | PMID 18134353 Get It

EFFECT OF THYROXINE AND THIOURACIL ON THE RATE OF PHOSPHOLIPID TURNOVER IN THE LIVER OF THE RAT
Flock, Eunice V., Bollman, Jesse L., Berkson, Joseph

Mayo Clinic

American Journal of Physiology-Legacy Content | December 25, 2017 | Volume: 155 | Issue: 3 | Pages: 402-408

10.1152/ajplegacy.1948.155.3.402 | PMID 18113180 Get It

Effect of renal interstitial adenosine infusion on phosphate excretion in diabetes mellitus rats
Pflueger, Axel , Berndt, Theresa J., Knox, Franklyn G.

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | December 25, 2017 | Volume: 274 | Issue: 5 | Pages: R1228-R1235

10.1152/ajpregu.1998.274.5.r1228 | PMID 9644034 Get It

We previously demonstrated an increased sensitivity of the renal vasculature to adenosine (ADO) mediated via ADO A1receptors in streptozotocin (STZ) diabetic rats. Because ADO stimulates Pireabsorption in the proximal tubule, the present study was performed to determine whether the sensitivity of the renal tubular system to the antiphosphaturic effect of ADO is enhanced in STZ rats. Clearance studies were performed, and ADO was infused into the renal interstitium via implanted matrices in STZ- and control (Con) rats to mimic the effects of endogenous ADO. Renal phosphate excretion was significantly increased in STZ rats (0.75 ± 0.05 μmol/24 h) compared with Con rats (0.35 ± 0.08 μmol/24 h), and fractional phosphate excretion ([Formula: see text]) tended to be higher in STZ rats (34.8 ± 4.1%) than in Con rats (26.7 ± 2.2%). Renal interstitial ADO infusion (5 μmol/h) was significantly more antiphosphaturic in STZ rats ([Formula: see text] decreased by 6.95 ± 1.36%; P < 0.05) than in Con rats ([Formula: see text] decreased by 2.90 ± 1.6%; P > 0.05), in which ADO only tended to decrease[Formula: see text]. To determine the role of ADO A1receptors on Piexcretion, the selective ADO A1receptor blocker 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) was infused into the renal interstitium. DPCPX increased[Formula: see text] by 4.3 ± 1.2% ( P < 0.05) in the presence and 7.1 ± 3.9% ( P < 0.05) in the absence of ADO infusion in Con rats but had no effect on[Formula: see text] in STZ rats. In conclusion, STZ-diabetes mellitus enhances the antiphosphaturic effect of ADO by mechanisms unrelated to ADO A1receptor stimulation.
MAINTENANCE OF VASODILATATION OF THE EXTREMITIES OF NORMAL INDIVIDUALS FOR A PROLONGED PERIOD BY THE INGESTION OF TWO TO FOUR SUBSTANTIAL MEALS IN CLOSE SUCCESSION
Roth, Grace M., Sheard, Charles

Mayo Clinic

American Journal of Physiology-Legacy Content | December 25, 2017 | Volume: 152 | Issue: 1 | Pages: 183-188

10.1152/ajplegacy.1947.152.1.183 | PMID 18903443 Get It

Disuse osteopenia is accompanied by downregulation of gene expression for bone proteins in growing rats
Wakley, Glenn K., Portwood, J. S., Turner, Russell T.

Mayo Clinic

American Journal of Physiology-Endocrinology and Metabolism | December 25, 2017 | Volume: 263 | Issue: 6 | Pages: E1029-E1034

10.1152/ajpendo.1992.263.6.e1029 Get It

Unilateral sciatic neurectomy (USN) resulted in cortical osteopenia in tibiae from the sciatic nerve-sectioned limb of growing rats. The bone deficit resulted from decreased periosteal addition; there were no changes in the indexes of bone resorption. The periosteal bone formation rate was reduced in the nerve-sectioned limb within 7 days of sciatic neurectomy, and this decrease persisted for at least 56 days. Steady-state mRNA levels for bone proteins were determined in periosteum isolated from tibiae and femurs 7 and 14 days after sciatic nerve section. Nerve section resulted in decreased levels of mRNA for osteocalcin, alkaline phosphatase, and possibly the prepro-alpha (I)-subunit of type I collagen (collagen). The effects were more pronounced in tibiae than femurs, corresponding to the greater degree of immobility induced by USN in the former bone. The results demonstrate that decreased bone formation precedes establishment of disuse cortical osteopenia in growing rats with no evidence for a change in bone resorption. Furthermore, the decreased bone formation is associated with, and may be due to, reduced mRNA levels for matrix proteins and other important bone proteins.